| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | KGD958X2B9 |
| InChI Key | OTXAMWFYPMNDME-FQQWJMKMSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C45H60ClN7O9S |
| Molecular Weight | 910.53 |
| AlogP | 6.2 |
| Hydrogen Bond Acceptor | 13.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 16.0 |
| Polar Surface Area | 193.78 |
| Molecular species | ACID |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 63.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Primary active transporter
ATP-binding cassette
ABCC subfamily
|
- | 12000 | - | - | - | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCG subfamily
|
- | 1400 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hepatitis C, Chronic | 2 | D019698 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2013174 |
| DrugBank | DB12037 |
| FDA SRS | KGD958X2B9 |
| PubChem | 25167947 |
| SureChEMBL | SCHEMBL10082460 |